Clinical study of pancuronium as muscle relaxant in anesthesia.
D000731:Androstanes / Q000494:pharmacology*; D000769:Anesthesia, Inhalation; D001158:Arteries; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D006221:Halothane / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008733:Methoxyflurane / Q000494:pharmacology; D009388:Neostigmine / Q000008:administration & dosage / Q000494:pharmacology; D009458:Neuroleptanalgesia; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D010197:Pancuronium / Q000008:administration & dosage / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D013390:Succinylcholine; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D000731:Androstanes; D003473:Neuromuscular Nondepolarizing Agents; D002245:Carbon Dioxide; D008733:Methoxyflurane; D009388:Neostigmine; D001285:Atropine; D013390:Succinylcholine; D010197:Pancuronium; D010100:Oxygen; D006221:Halothane